1. Academic Validation
  2. A Persulfide Donor Responsive to Reactive Oxygen Species: Insights into Reactivity and Therapeutic Potential

A Persulfide Donor Responsive to Reactive Oxygen Species: Insights into Reactivity and Therapeutic Potential

  • Angew Chem Int Ed Engl. 2018 May 22;57(21):6324-6328. doi: 10.1002/anie.201803087.
Chadwick R Powell 1 Kearsley M Dillon 1 Yin Wang 1 Ryan J Carrazzone 1 John B Matson 1
Affiliations

Affiliation

  • 1 Department of Chemistry, Virginia Tech Center for Drug Discovery, Macromolecules Innovation Institute, Virginia Tech, Blacksburg, VA, 24061, USA.
Abstract

Persulfides (RSSH) have been hypothesized as critical components in sulfur-mediated redox cycles and as potential signaling compounds, similar to hydrogen sulfide (H2 S). Hindering the study of persulfides is a lack of persulfide-donor compounds with selective triggers that release discrete persulfide species. Reported here is the synthesis and characterization of a ROS-responsive (ROS=reactive oxygen species), self-immolative persulfide donor. The donor, termed BDP-NAC, showed selectivity towards H2 O2 over Other potential oxidative or nucleophilic triggers, resulting in the sustained release of the persulfide of N-acetyl cysteine (NAC) over the course of 2 h, as measured by LCMS. Exposure of H9C2 cardiomyocytes to H2 O2 revealed that BDP-NAC mitigated the effects of a highly oxidative environment in a dose-dependent manner over relevant controls and to a greater degree than common H2 S donors sodium sulfide (Na2 S) and GYY4137. BDP-NAC also rescued cells more effectively than a non-persulfide-releasing control compound in concert with common H2 S donors and thiols.

Keywords

drug delivery; fluoresence; hydrogen sulfide; persulfide; reactive oxygen species.

Figures
Products